Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia Harbeck

Showing results (11-20 of 585) with videos related to

Pageof 59
Sort By:
Future Oncology (London, England)|October 11, 2013
American Society of Clinical Oncology highlights 2013: breast cancer and gynecological malignanciesNadia Harbeck
MMW Fortschritte Der Medizin|March 7, 2003
[Interview with private lecturer Dr. med. Nadia Harbeck, Munich. Prognostic markers guide therapy (interview by Jochen Aumiller)]Nadia Harbeck
Current Opinion in Obstetrics & Gynecology|December 18, 2020
Risk-adapted adjuvant therapy of luminal early breast cancer in 2020Nadia Harbeck
The Oncologist|February 1, 2011
A new look at node-negative breast cancerNadia Harbeck, Christoph Thomssen
Onkologie|December 3, 2010
Chemotherapy is not the end of the road in young cancer patients who still want to become pregnantNadia Harbeck, Sabine Latta
MMW Fortschritte Der Medizin|August 16, 2019
Nadia Harbeck, Sven Mahner
Current Opinion in Obstetrics & Gynecology|December 3, 2009
Angiogenesis inhibitors in the management of breast cancerVerena Bossung, Nadia Harbeck
Lancet (London, England)|November 21, 2016
Breast cancerNadia Harbeck, Michael Gnant
Breast Care (Basel, Switzerland)|February 20, 2014
ABC2 Consensus Conference on Advanced Breast Cancer: Brief Summary of the Consensus Panel on Saturday November 9, 2013Christoph Thomssen, Nadia Harbeck
Breast Cancer Research and Treatment|November 21, 2007
The patient experienceNadia Harbeck, Renate Haidinger
Pageof 59

Showing results (11-20 of 585) with videos related to

Sort By:
Pageof 59
Future Oncology (London, England)|October 11, 2013
American Society of Clinical Oncology highlights 2013: breast cancer and gynecological malignanciesNadia Harbeck
MMW Fortschritte Der Medizin|March 7, 2003
[Interview with private lecturer Dr. med. Nadia Harbeck, Munich. Prognostic markers guide therapy (interview by Jochen Aumiller)]Nadia Harbeck
Current Opinion in Obstetrics & Gynecology|December 18, 2020
Risk-adapted adjuvant therapy of luminal early breast cancer in 2020Nadia Harbeck
The Oncologist|February 1, 2011
A new look at node-negative breast cancerNadia Harbeck, Christoph Thomssen
Onkologie|December 3, 2010
Chemotherapy is not the end of the road in young cancer patients who still want to become pregnantNadia Harbeck, Sabine Latta
MMW Fortschritte Der Medizin|August 16, 2019
Nadia Harbeck, Sven Mahner
Current Opinion in Obstetrics & Gynecology|December 3, 2009
Angiogenesis inhibitors in the management of breast cancerVerena Bossung, Nadia Harbeck
Lancet (London, England)|November 21, 2016
Breast cancerNadia Harbeck, Michael Gnant
Breast Care (Basel, Switzerland)|February 20, 2014
ABC2 Consensus Conference on Advanced Breast Cancer: Brief Summary of the Consensus Panel on Saturday November 9, 2013Christoph Thomssen, Nadia Harbeck
Breast Cancer Research and Treatment|November 21, 2007
The patient experienceNadia Harbeck, Renate Haidinger
Pageof 59